PATH | VRL
Menu

Quantifying Maternally Derived Respiratory Syncytial Virus Specific Neutralising Antibodies in a Birth Cohort From Coastal Kenya

This article, published in Vaccine, reports on the characteristics of respiratory syncytial virus (RSV) neutralizing antibodies in a birth cohort in Kilifi, Kenya, which provides important data for maternal RSV vaccine development. Results showed the levels of cord RSV antibodies to increase during seasonal virus transmission. The rate of decay of RSV antibodies following birth was also found to be independent of cord titer. The study also showed a high degree of variation between individuals in rate of decay.

Author: Nyiro JU, Sande C, Mutunga M, et al.

Published: 2015

» Visit web page (English)

(Located at www.sciencedirect.com)

Citation: Nyiro JU, Sande C, Mutunga M, et al. Quantifying Maternally Derived Respiratory Syncytial Virus Specific Neutralising Antibodies in a Birth Cohort From Coastal Kenya. Vaccine. 2015;33(15):1797-1801.

Resource types: Peer-reviewed journal

Diseases/vaccines: Respiratory syncytial virus (RSV)

Topics: Disease/vaccine specific information

Regions: Africa